Placenta Previa Clinical Trial
Official title:
The Prediction of Risk Factors of Progression of Low Implanted Placenta at 18- 24 Weeks to Placenta Previa at Term
Placenta Previa is defined as a placenta implanted in the lower segment of the uterus,
presenting ahead of the leading pole of the fetus (over or near the internal os). The
prevalence of placenta previa has been estimated to be approximately 0.5% of all pregnancies,
and this increase correlates to the elevated cesarean section rate . In Egypt, the prevalence
of placenta previa is around 1.3% in Sohag Governorate and 1.5% in Aswan region according to.
Although various studies have tried to address risk factors associated with Placenta Previa
development, the etiology of placenta previa still remains obscure. Several risk actors have
been identified as strong contributors to placenta previa development. It is also a
significant contributor to severe postpartum hemorrhage.Risk factors include; history of
previous cesarean section, advanced maternal age, history of previous abortions, high parity
and substance abuse during pregnancy (cigarette smoking), placental size (multiple
pregnancy), endometrial damage (previous dilatation and curettage), uterine scars and
pathology (previous myomectomy or endometritis), placental pathology (marginal cord
insertions and succenturiate lobes), previous placental Previa, and curiously.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04518163 -
Bakri Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa
|
N/A | |
| Recruiting |
NCT04518150 -
Combined Bilateral Uterine Artery Ligation and Bakri Balloon During Cesarean Section
|
N/A | |
| Recruiting |
NCT03638024 -
Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
|
||
| Terminated |
NCT01996345 -
Vaginal Pessary Versus Expectant Management for Placenta Previa
|
N/A | |
| Recruiting |
NCT04609527 -
Management of Placenta Accreta Spectrum
|
Phase 2/Phase 3 | |
| Completed |
NCT03321435 -
The Placenta Previa and Fetal Weight
|
N/A | |
| Enrolling by invitation |
NCT05529381 -
Anxiety and Depressive Symptoms in Placenta Previa / Accreta
|
||
| Completed |
NCT04264234 -
Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria
|
N/A | |
| Completed |
NCT05340205 -
Blood Loss During Cesarean Delivery in Placenta Previa Patients
|
Phase 4 | |
| Completed |
NCT03570723 -
Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa
|
N/A | |
| Completed |
NCT05283122 -
Mostafa Maged Technique to Control and Prevent the Post-Partum Bleeding From the Lower Uterine Segment in Placenta Previa Cases
|
N/A | |
| Withdrawn |
NCT01442207 -
Cerclage for Prevention on Preterm Birth in Women With Placenta Previa
|
Phase 3 | |
| Not yet recruiting |
NCT03451136 -
Cervical Length in Cases of Placenta Previa
|
N/A | |
| Completed |
NCT02966197 -
Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta
|
N/A | |
| Recruiting |
NCT02590484 -
The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta
|
N/A | |
| Recruiting |
NCT05802251 -
Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study
|
||
| Completed |
NCT03542552 -
Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa
|
Phase 3 | |
| Recruiting |
NCT03124472 -
Effect of Uterine Artery Ligation Prior to Uterine Incision in Women With Placenta Previa
|
N/A | |
| Recruiting |
NCT03633175 -
Progesterone in Patients With Placenta Previa
|
Phase 2 | |
| Not yet recruiting |
NCT03208842 -
Relation of Implantation Site to Placental Site in Presence or Absence of Cesarean Section Scar
|
N/A |